» Articles » PMID: 28785562

Obesity and Kidney Disease: Hidden Consequences of the Epidemic

Overview
Specialty Nephrology
Date 2017 Aug 9
PMID 28785562
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Obesity has become a worldwide epidemic, and its prevalence has been projected to grow by 40% in the next decade. This increasing prevalence has implications for the risk of diabetes, cardiovascular disease, and also for chronic kidney disease. A high body mass index is one of the strongest risk factors for new-onset chronic kidney disease. In individuals affected by obesity, a compensatory hyperfiltration occurs to meet the heightened metabolic demands of the increased body weight. The increase in intraglomerular pressure can damage the kidneys and raise the risk of developing chronic kidney disease in the long-term. The incidence of obesity-related glomerulopathy has increased 10-fold in recent years. Obesity has also been shown to be a risk factor for nephrolithiasis, and for a number of malignancies including kidney cancer. This year, the World Kidney Day promotes education on the harmful consequences of obesity and its association with kidney disease, advocating healthy lifestyle and health policy measures that make preventive behaviors an affordable option.

Citing Articles

Rodent models of AKI and AKI-CKD transition: an update in 2024.

Fu Y, Xiang Y, Wei Q, Ilatovskaya D, Dong Z Am J Physiol Renal Physiol. 2024; 326(4):F563-F583.

PMID: 38299215 PMC: 11208034. DOI: 10.1152/ajprenal.00402.2023.


COVID-19 in Chronic Kidney Disease: The Impact of Old and Novel Cardiovascular Risk Factors.

Podesta M, Valli F, Galassi A, Cassia M, Ciceri P, Barbieri L Blood Purif. 2021; 50(6):740-749.

PMID: 33752209 PMC: 8089440. DOI: 10.1159/000514467.


Obesity in the critically ill: a narrative review.

Schetz M, De Jong A, Deane A, Druml W, Hemelaar P, Pelosi P Intensive Care Med. 2019; 45(6):757-769.

PMID: 30888440 DOI: 10.1007/s00134-019-05594-1.


Glomerular Hyperfiltration as Predictor of Cardiometabolic Risk Factors among Children and Adolescents: The Childhood and Adolescence Surveillance and Prevention of Adult-V Study.

Kelishadi R, Qorbani M, Assadi F, Motlagh M, Djalalinia S, Shahsavari A Int J Prev Med. 2018; 9:33.

PMID: 29619157 PMC: 5869957. DOI: 10.4103/ijpvm.IJPVM_38_18.

References
1.
Iseki K, Ikemiya Y, Kinjo K, Inoue T, Iseki C, Takishita S . Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int. 2004; 65(5):1870-6. DOI: 10.1111/j.1523-1755.2004.00582.x. View

2.
Kalantar-Zadeh K, Kuwae N, Wu D, Shantouf R, Fouque D, Anker S . Associations of body fat and its changes over time with quality of life and prospective mortality in hemodialysis patients. Am J Clin Nutr. 2006; 83(2):202-10. DOI: 10.1093/ajcn/83.2.202. View

3.
Ruster C, Wolf G . The role of the renin-angiotensin-aldosterone system in obesity-related renal diseases. Semin Nephrol. 2013; 33(1):44-53. DOI: 10.1016/j.semnephrol.2012.12.002. View

4.
Foster M, Hwang S, Massaro J, Hoffmann U, deBoer I, Robins S . Association of subcutaneous and visceral adiposity with albuminuria: the Framingham Heart Study. Obesity (Silver Spring). 2010; 19(6):1284-9. PMC: 3096746. DOI: 10.1038/oby.2010.308. View

5.
Vivante A, Golan E, Tzur D, Leiba A, Tirosh A, Skorecki K . Body mass index in 1.2 million adolescents and risk for end-stage renal disease. Arch Intern Med. 2012; 172(21):1644-50. PMC: 4941233. DOI: 10.1001/2013.jamainternmed.85. View